KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jazz Pharmaceuticals (JAZZ) Non-Current Deffered Revenue (2016 - 2022)

Historic Non-Current Deffered Revenue for Jazz Pharmaceuticals (JAZZ) over the last 13 years, with Q3 2022 value amounting to $116000.0.

  • Jazz Pharmaceuticals' Non-Current Deffered Revenue fell 8823.53% to $116000.0 in Q3 2022 from the same period last year, while for Sep 2022 it was $116000.0, marking a year-over-year decrease of 8823.53%. This contributed to the annual value of $463000.0 for FY2021, which is 8000.0% down from last year.
  • According to the latest figures from Q3 2022, Jazz Pharmaceuticals' Non-Current Deffered Revenue is $116000.0, which was down 8823.53% from $231000.0 recorded in Q2 2022.
  • Jazz Pharmaceuticals' Non-Current Deffered Revenue's 5-year high stood at $13.6 million during Q1 2018, with a 5-year trough of $116000.0 in Q3 2022.
  • Over the past 5 years, Jazz Pharmaceuticals' median Non-Current Deffered Revenue value was $3.6 million (recorded in 2020), while the average stood at $4.8 million.
  • Its Non-Current Deffered Revenue has fluctuated over the past 5 years, first crashed by 3841.36% in 2019, then plummeted by 8823.53% in 2022.
  • Over the past 5 years, Jazz Pharmaceuticals' Non-Current Deffered Revenue (Quarter) stood at $9.6 million in 2018, then tumbled by 49.26% to $4.9 million in 2019, then crashed by 52.38% to $2.3 million in 2020, then crashed by 80.0% to $463000.0 in 2021, then plummeted by 74.95% to $116000.0 in 2022.
  • Its Non-Current Deffered Revenue was $116000.0 in Q3 2022, compared to $231000.0 in Q2 2022 and $347000.0 in Q1 2022.